Introduction and first vote
Date | 29 September 2014 |
Event | ESMO 2014 |
Session | Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT) |
Topics | Anticancer Agents Prostate Cancer Therapy Biological Therapy |
Presenter | Eleni Efstathiou |
Authors |
E. Efstathiou
|